Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,472,168
-
Share change
-
+755,539
-
Total reported value
-
$141,218,086
-
Put/Call ratio
-
129%
-
Price per share
-
$12.31
-
Number of holders
-
82
-
Value change
-
+$10,110,140
-
Number of buys
-
42
-
Number of sells
-
23
Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) as of Q2 2016
As of 30 Jun 2016,
ONCOMED PHARMACEUTICALS INC - COM (OMED) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,472,168 shares.
The largest 10 holders included
ADAMS STREET PARTNERS LLC, BVF INC/IL, FMR LLC, BlackRock Fund Advisors, Iguana Healthcare Management, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., MILLENNIUM MANAGEMENT LLC, DISCIPLINED GROWTH INVESTORS INC /MN, and FRANKLIN RESOURCES INC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.